Evogene Ltd.EVGNNASDAQ
Loading
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -53.81% | +178.72% | -41.67% | +46.12% | -82.07% |
| Gross Profit Growth | -81.16% | +0.00% | -92.18% | +0.00% | -125.77% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +18.70% | +34.34% | +34.29% | +41.93% | +50.10% |
| Weighted Average Shares Diluted Growth | +18.70% | +34.34% | +34.29% | +41.93% | +50.10% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +22.86% | +84.95% | -10.89% | -56.04% | -90.41% |
| Inventory Growth | +1188.50% | +2293.42% | +200.56% | +146.22% | +44.99% |
| Asset Growth | -30.53% | -21.99% | -26.67% | -17.19% | -34.97% |
| Book Value per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Debt Growth | -4.56% | +11.89% | +14.27% | -41.26% | -77.10% |
| R&D Expense Growth | -29.67% | -42.48% | -36.34% | -20.42% | -64.66% |
| SG&A Expenses Growth | +39.44% | -10.65% | -26.72% | -25.51% | -54.87% |